Net Income

Amid rising cyber threats, Availity’s award-winning framework promises a 5-day recovery, challenging the industry to move beyond defense to resilience.

Vericel posts strong 2025 results driven by its MACI cartilage therapy. The biotech leader is now investing in a new facility and a clinical trial for ankle repair.

AI promises to slash doctor burnout and paperwork, giving physicians more time with patients while boosting practice profitability. But can it deliver?

The AI firm announced record 2025 growth, leveraging deep partnerships with Google and Adobe to deliver award-winning, practical marketing solutions.

Kye Pharma brings SLENYTO®, a first-of-its-kind prescription sleep aid, to Canada, offering relief to children with ASD and SMS and their families.

Nukkleus Inc. completes its acquisition of Star 26 Capital, pivoting to defense tech and aiming to fix critical supply chain issues amid market volatility.

Amid market pressures, VirTra showcases its advanced training simulators at SHOT Show, betting on immersive tech to redefine law enforcement training.

A new leveraged ETF offers traders a 2x daily bet on lunar pioneer Intuitive Machines, igniting debate over speculation and risk in the new space economy.

goHappy launches Smart Reply, an app-free tool using simple text messages to bring structured, two-way communication to frontline teams, replacing messy group chats.

MedTech firm Lifeward is acquiring Oramed's oral insulin tech, despite a past trial failure, in a high-stakes deal that could redefine both companies.

Medical device firm CVRx is under investigation after its stock nosedived. Did management mislead investors about its salesforce stability?

As cannabis moves to Schedule III, a top consulting firm unveils expert witness and lab services to navigate a new landscape of regulation and litigation.

Beyond oral care, Colgate-Palmolive is reshaping rural India with initiatives in water conservation, digital literacy, and waste management.

The eyecare tech firm reports a strong fourth quarter fueled by its TearCare system, even as full-year results show a slight dip. Is this a turning point?

A landmark $1B DoD investment will spin off L3Harris's missile division into a public company, aiming to solve a critical rocket motor shortage.

GDS Holdings converts a minority stake into a massive payday, recycling capital at a 6.5x multiple to double down on China's booming AI infrastructure.

Cricket legend Sachin Tendulkar is the new face of Techno Paints as the firm eyes a Rs. 500 crore IPO and aims to challenge giants in India's paint market.

French insurer Groupama launches a pioneering catastrophe bond targeting hail, a novel financial shield against escalating climate-driven storm losses.

As NorthWestern Energy preps its 2025 results, investors eye the impact of a major merger, tough rate battles, and big bets on data center growth.

The first-ever Wegovy pill is now available via telehealth platform Ro, offering a cash-pay option that could revolutionize access to weight loss drugs.